You have 9 free searches left this month | for more free features.

T3011

Showing 1 - 25 of 181

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Melanoma, Malignant Melanoma Trial (T3011 + Cobimetinib)

Not yet recruiting
  • Melanoma
  • Malignant Melanoma
  • T3011 + Cobimetinib
  • (no location specified)
Mar 3, 2023

Advanced Solid Tumor, Sarcoma, HNSCC Trial in China (T3011)

Recruiting
  • Advanced Solid Tumor
  • +6 more
  • T3011
  • Hefei, Anhui, China
  • +18 more
Oct 30, 2022

Advanced Solid Tumor, Lung Cancer, Liver Cancer Trial in China (T3011)

Recruiting
  • Advanced Solid Tumor
  • +4 more
  • T3011
  • Bengbu, Anhui, China
  • +6 more
Oct 24, 2022

Metastasis in Lung, Metastasis in Liver, Solid Tumor Trial in United States (T3011, T3011 + pembrolizumab)

Recruiting
  • Metastasis in Lung
  • +3 more
  • T3011
  • T3011 + pembrolizumab
  • Phoenix, Arizona
  • +3 more
Aug 26, 2021

Solid Tumor, Melanoma, NSCLC Trial in Australia, United States (T3011, T3011 + pembrolizumab)

Recruiting
  • Solid Tumor
  • +2 more
  • T3011
  • T3011 + pembrolizumab
  • Gilbert, Arizona
  • +7 more
Jun 22, 2021

Type 1 Diabetes Trial in Nijmegen, Rotterdam (gallium-68-exendin injection followed by PET/CT scan)

Recruiting
  • Type 1 Diabetes Mellitus
  • gallium-68-exendin injection followed by PET/CT scan
  • Nijmegen, Gelderland, Netherlands
  • +1 more
Oct 8, 2020

Breast Reconstruction, Implant-Based Breast Reconstruction (IBBR) Trial in Worldwide (pre-pectoral IBBR, sub-pectoral IBBR)

Recruiting
  • Breast Reconstruction
  • Implant-Based Breast Reconstruction (IBBR)
  • pre-pectoral IBBR
  • sub-pectoral IBBR
  • Boston, Massachusetts
  • +24 more
Nov 1, 2021

Embolic Stroke of Undetermined Source Trial in Worldwide

Completed
  • Embolic Stroke of Undetermined Source
    • Stanford, California
    • +43 more
    Feb 3, 2021

    Multiple Myeloma Trial in Worldwide (Dexamethasone, Daratumumab, Venetoclax)

    Active, not recruiting
    • Multiple Myeloma
    • Aurora, Colorado
    • +39 more
    Mar 2, 2022

    Upper Limb Essential Tremor (UL ET) Trial in Canada, United States (BOTOX, Placebo for BOTOX)

    Recruiting
    • Upper Limb Essential Tremor (UL ET)
    • BOTOX
    • Placebo for BOTOX
    • Hoover, Alabama
    • +39 more
    Aug 22, 2022

    Staphylococcus Aureus Bacteremia Trial in Worldwide (Cefazolin, Penicillin, Clindamycin)

    Recruiting
    • Staphylococcus Aureus Bacteremia
    • Garran, Australia Capital Territory, Australia
    • +73 more
    Feb 23, 2022

    Non Hodgkin Lymphoma Trial in Worldwide (Epcoritamab)

    Recruiting
    • Non Hodgkin Lymphoma
    • Palo Alto, California
    • +44 more
    Aug 12, 2022

    Cataract Trial in Worldwide (ACRYSOF® IQ Extended Depth of Focus IOL, ACRYSOF® IQ Monofocal IOL, Cataract surgery)

    Completed
    • Cataract
    • ACRYSOF® IQ Extended Depth of Focus IOL
    • +2 more
    • Sydney, New South Wales, Australia
    • +20 more
    Mar 25, 2020

    Hepatitis D, Chronic Trial in Worldwide (JNJ-73763989, Placebo, Entecavir (ETV) monohydrate)

    Recruiting
    • Hepatitis D, Chronic
    • Los Angeles, California
    • +76 more
    Aug 2, 2022

    NSCLC Trial in Worldwide (Denosumab, Zoledronic acid, Placebo to Denosumab)

    Completed
    • Non-Small Cell Lung Cancer
    • Goodyear, Arizona
    • +73 more
    Oct 4, 2021

    Eosinophilic Esophagitis Trial in Worldwide (CC-93538)

    Recruiting
    • Eosinophilic Esophagitis
    • Birmingham, Alabama
    • +300 more
    Aug 17, 2022

    Eosinophilic Esophagitis Trial in Worldwide (CC-93538, Placebo)

    Recruiting
    • Eosinophilic Esophagitis
    • Birmingham, Alabama
    • +369 more
    Jul 21, 2022

    Crohn's Disease Trial in Worldwide (Guselkumab, Golimumab, JNJ-78934804)

    Not yet recruiting
    • Crohn's Disease
    • Guselkumab
    • +3 more
    • Birmingham, Alabama
    • +167 more
    Jul 14, 2022

    Pulmonary Disease, Chronic Obstructive Trial in Worldwide (Danirixin, Danirixin matching , Standard of care)

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • Birmingham, Alabama
    • +63 more
    Oct 6, 2020

    HBV, Chronic HBV Infection Trial in Worldwide (TAF, TDF, TAF Placebo)

    Active, not recruiting
    • HBV
    • Chronic HBV Infection
    • Los Angeles, California
    • +159 more
    Mar 17, 2022

    Endometrial Tumors Trial in Worldwide (Paclitaxel, Sapanisertib, MLN1117)

    Completed
    • Endometrial Neoplasms
    • Birmingham, Alabama
    • +77 more
    Oct 28, 2021

    Lung Cancer Trial in Worldwide (PF-00299804, Placebo)

    Completed
    • Lung Cancer
    • Arcadia, California
    • +88 more
    Apr 7, 2020

    Type 1 Diabetes Trial in Worldwide (Teplizumab, Placebo)

    Completed
    • Type 1 Diabetes Mellitus
    • Birmingham, Alabama
    • +114 more
    Feb 4, 2022

    Tumors, Cancer, Caregiver Trial in Philadelphia

    Recruiting
    • Neoplasms
    • +2 more
      • Philadelphia, Pennsylvania
        Cancer Support Community Research & Training Institute
      Jan 30, 2022

      Ulcerative Colitis Trial in Worldwide (Adalimumab, Adalimumab Placebo, Etrolizumab)

      Completed
      • Ulcerative Colitis
      • Orlando, Florida
      • +89 more
      Jul 21, 2021